Headquartered in London, LGC is an international life sciences measurement and analytical testing company serving pharmaceutical, food, environmental and government markets. It has more than 40,000 customers in 150 countries, including America, India, China, Russia and Brazil. Following investment in 2015 by private equity firm KKR, sales this year rose 22% to £302.7m. The group has made 19 acquisitions since 2011, and seven in the past year, including, in March, German firm Axolabs, which develops therapeutic oligonucleotides for the treatment of genetic disorders. Tim Robinson, 54, is chief executive.